Press "Enter" to skip to content

New patent expiration for Novo Nordisk drug VICTOZA

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Novo Nordisk drug VICTOZA

Annual Drug Patent Expirations for VICTOZA
Annual Drug Patent Expirations for VICTOZA

Victoza is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers. There are eight patents protecting this drug and one Paragraph IV challenge.

VICTOZA drug price trends.

Drug patent litigation for VICTOZA.

The generic ingredient in VICTOZA is liraglutide recombinant. Two suppliers are listed for this compound. Additional details are available on the liraglutide recombinant profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Novo Nordisk drug VICTOZA
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    DrugPatentWatch - Make Better Decisions